Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Br J Haematol ; 158(3): 363-9, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22624626

RESUMO

Severe congenital neutropenia (SCN) is characterized by low blood neutrophil counts, early bacterial infections, and risk of leukaemia development. As yet, no population-based incidence estimates of SCN have been reported. Children less than 16 years of age with SCN were sought in Sweden during the 20-year period 1987-2006 by a questionnaire to all Swedish Departments of Paediatrics and by reviewing the Swedish Health and Welfare Statistical Databases. Thirty-two patients were diagnosed with congenital neutropenia during this period. All received treatment with recombinant granulocyte-colony stimulating factor (G-CSF). Twenty-one patients were diagnosed as SCN or probable SCN, corresponding to 1·0 per 100,000 live births. Nine (43%) had ELANE mutations, four (19%) HAX1 mutations and eight (38%) were children with disease of unknown genetic aetiology. Four out of 21 patients (19%) developed myelodysplastic syndrome/leukaemia and three (14%) died, all with leukaemia. The cumulative incidence of myelodysplastic syndrome/leukaemia was 31%. The observed incidence of SCN in this population-based study was higher than previously estimated, possibly because genetic testing now can identify SCN cases previously thought to be idiopathic or benign neutropenia. The risk of developing myelodysplastic syndrome/leukaemia is considerable. ELANE mutations are the most commonly identified genetic defects.


Assuntos
Síndromes Mielodisplásicas/epidemiologia , Neutropenia/congênito , Adolescente , Adulto , Criança , Pré-Escolar , Síndrome Congênita de Insuficiência da Medula Óssea , Feminino , Predisposição Genética para Doença , Humanos , Incidência , Lactente , Masculino , Síndromes Mielodisplásicas/genética , Neutropenia/epidemiologia , Neutropenia/genética , Fatores de Risco , Suécia/epidemiologia , Adulto Jovem
2.
Acta Paediatr ; 101(3): 313-8, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22017632

RESUMO

AIM: Haemophagocytic lymphohistiocytosis (HLH) is a life-threatening disturbance of immunoregulation. HLH comprises primary and acquired forms with different disease severity. A large proportion of deaths occur early into treatment. We investigated association with early death for laboratory and clinical parameters before the start of and 2 weeks into therapy. METHODS: A total of 232 children from Scandinavia, Germany or Italy, fulfilling diagnostic criteria and/or with familial disease and/or HLH-causing mutations, receiving HLH treatment 1994-2008 were included. The relation between clinical findings and early pre-transplant death was examined using the Cox proportional hazards model, with a 4-month right-truncation of the outcome. Patients were censored at last follow-up or transplant. Statistically significant predictors were adjusted for sex, age and each other. RESULTS: The following features were significantly associated with adverse outcome: hyperbilirubinaemia (>50 µmol/L; adjusted hazard ratio (aHR) 3.2; 95% confidence interval 1.3-8.1, p = 0.011), hyperferritinaemia (>2000 µg/L; aHR 3.2; 1.2-8.6, p = 0.019), cerebrospinal fluid pleocytosis (>100 × 10(6) /L; aHR 5.1; 1.4-18.5, p = 0.012) at diagnosis, and thrombocytopenia (<40 × 10(9) /L; aHR 3.4; 1.1-10.7, p = 0.033), and hyperferritinaemia (>2000 µg/L; aHR 10.6; 1.2-96.4, p = 0.037) 2 weeks into therapy. Non-improvement of fever, anaemia and/or thrombocytopenia also had adverse impact. CONCLUSION: There seem to be easily available clinical predictors of early mortality in HLH patients, which may help guide treatment decisions.


Assuntos
Linfo-Histiocitose Hemofagocítica/mortalidade , Adolescente , Anti-Inflamatórios/uso terapêutico , Criança , Ciclosporina/uso terapêutico , Dexametasona/uso terapêutico , Quimioterapia Combinada , Etoposídeo/uso terapêutico , Feminino , Ferritinas/sangue , Febre/etiologia , Humanos , Hiperbilirrubinemia/etiologia , Imunossupressores/uso terapêutico , Leucocitose/líquido cefalorraquidiano , Leucocitose/etiologia , Linfo-Histiocitose Hemofagocítica/complicações , Linfo-Histiocitose Hemofagocítica/tratamento farmacológico , Linfo-Histiocitose Hemofagocítica/metabolismo , Masculino , Prognóstico , Modelos de Riscos Proporcionais , Fatores de Risco , Trombocitopenia/etiologia
3.
J Comp Neurol ; 501(3): 431-42, 2007 Mar 20.
Artigo em Inglês | MEDLINE | ID: mdl-17245706

RESUMO

Rat fetal ventral mesencephalic organotypic cultures have demonstrated two morphologically different dopamine nerve fiber growth patterns, in which the initial nerve fibers are formed in the absence of astrocytes and the second wave is guided by astrocytes. In this study, the presence of subpopulations of dopamine neurons, other neuronal populations, and glial cells was determined. We used "roller-drum" organotypic cultures, and the results revealed that beta-tubulin-positive/tyrosine hydroxylase (TH)-negative nerve fibers were present as early as 1 day in vitro (DIV). A similar growth pattern produced by TH-positive neurons was present from 2 DIV. These neurites grew to reach distances over 4 mm and over time appeared to be degenerating. Thin, vimentin-positive processes were found among these nerve fibers. As the first growth was retracted, a second outgrowth was initiated and formed on migrating astrocytes. TH- and aldehyde dehydrogenase-1 (ALDH1)-positive nerve fibers formed both the nonglia-associated and the glia-associated outgrowth. In cultures with membrane inserts, only the glia-associated outgrowth was found. Vimentin-positive cells preceded migration of NG2-positive oligodendrocytes and Iba-1-positive microglia. Oligodendrocytes appeared not to be involved in guiding neuritic growth, but microglia was absent over areas dense with TH-positive neurons. In conclusion, in "roller-drum" cultures, nerve fibers are generally formed in two sequences. The early-formed nerve fibers grow in the presence of thin, vimentin-positive processes. The second nerve fiber outgrowth is formed on astroglia, with no correlation to the presence of oligodendrocytes or microglia. ALDH1-positive nerve fibers, presumably derived from A9 dopamine neurons, participate in formation of both sequences of outgrowth.


Assuntos
Mesencéfalo/citologia , Fibras Nervosas/fisiologia , Neuroglia/citologia , Neurônios/fisiologia , Aldeído Desidrogenase/metabolismo , Família Aldeído Desidrogenase 1 , Animais , Dopamina/metabolismo , Glutamato Descarboxilase/metabolismo , Imuno-Histoquímica , Isoenzimas/metabolismo , Mesencéfalo/embriologia , Neuroglia/fisiologia , Técnicas de Cultura de Órgãos , Ratos , Ratos Sprague-Dawley , Retinal Desidrogenase , Células-Tronco/citologia , Células-Tronco/metabolismo , Tubulina (Proteína)/metabolismo , Vimentina/metabolismo
4.
J Neuroimmunol ; 139(1-2): 36-43, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12799018

RESUMO

The recently discovered IL-1F9 (IL-1H1) is a putative member of the interleukin (IL)-1 family of cytokines that has been shown to activate nuclear factor-kappa B (NFkappaB) in Jurkat cells transfected with the orphan receptor IL-1 receptor-related protein (IL-1Rrp)2. The aim of the present study was therefore to investigate expression of IL-1Rrp2 and to determine if IL-1F9 induces known IL-1 signaling pathways in the different cell types of the mouse brain in culture. Messenger RNA for IL-1Rrp2 was not detected in primary neurones by RT-PCR, but significant constitutive expression was found in mixed glial cells, particularly in astrocytes and microglia, which was strongly decreased by exposure to bacterial lipopolysaccharide (LPS). LPS induced the release of IL-6, and activated NFkappaB and the mitogen-activated protein kinases (MAPKs) p38, extracellular signal-regulated protein kinase (ERK1/2) and c-Jun N-terminal kinase (JNK) in microglial cultures. IL-1beta induced release of IL-6 and activated NFkappaB, p38, JNK and ERK1/2 in mixed glial cultures, which was completely abolished in the presence of IL-1 receptor antagonist (IL-1ra). When injected intracerebroventrically in the rat, IL-1beta increased core body temperature, and reduced body weight and food intake. In contrast, IL-1F9 failed to induce any of these responses either in vivo or in vitro. These results demonstrate that glial cells may be a target for the new ligand IL-1F9, since high expression of IL-1Rrp2 mRNA was detected in these cells. However, IL-1F9 failed to induce any of the classical IL-1beta responses, suggesting that it may trigger alternative pathway(s).


Assuntos
Encefalopatias/metabolismo , Encéfalo/metabolismo , Interleucina-1/metabolismo , Neuroglia/metabolismo , Proteínas/genética , Receptores de Interleucina/genética , Animais , Animais Recém-Nascidos , Astrócitos/efeitos dos fármacos , Astrócitos/imunologia , Astrócitos/metabolismo , Encéfalo/imunologia , Encefalopatias/imunologia , Encefalopatias/fisiopatologia , Células Cultivadas , Técnicas de Cocultura , Feto , Regulação da Expressão Gênica/imunologia , Proteína Antagonista do Receptor de Interleucina 1 , Interleucina-1/imunologia , Interleucina-1/farmacologia , Subunidade alfa de Receptor de Interleucina-18 , Interleucina-6/metabolismo , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Microglia/efeitos dos fármacos , Microglia/imunologia , Microglia/metabolismo , NF-kappa B/metabolismo , Neuroglia/imunologia , RNA Mensageiro/metabolismo , Receptores de Interleucina-18 , Sialoglicoproteínas/farmacologia
5.
Exp Neurol ; 216(1): 158-65, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19150447

RESUMO

Parkinson's disease is a neurodegenerative disorder where dopamine neurons in the substantia nigra of ventral mesencephalon undergo degeneration. In addition to the loss of dopamine neurons, noradrenaline neurons in the locus coeruleus degenerate, actually to a higher extent than the dopamine neurons. The interaction between these two nuclei is yet not fully known, hence this study was undertaken to investigate the role of locus coeruleus during development of dopamine neurons utilizing the intraocular grafting model. Fetal ventral mesencephalon and locus coeruleus were implanted either as single grafts or co-grafts, placed in direct contact or at a distance. The results revealed that the direct attachment of locus coeruleus to ventral mesencephalon enhanced graft volume and number of tyrosine hydroxylase (TH)-positive neurons in ventral mesencephalic grafts. Cell counts of subpopulations of TH-positive neurons also immunoreactive for aldehyde dehydrogenase 1-A1 (ALDH1) or calbindin, revealed improved survival of ALDH1/TH-positive neurons. However, the number of calbindin/TH-positive neurons was not affected. High density of dopamine-beta-hydroxylase (DBH)-positive innervation in the ventral mesencephalon placed adjacent to locus coeruleus was correlated to the improved survival. Ventral mesencephalic tissue, implanted at a distance to locus coeruleus, did not demonstrate improved survival, although DBH-positive nerve fibers were detected. In conclusion, the direct contact of locus coeruleus resulting in dense noradrenergic innervation of ventral mesencephalon is beneficial for the survival of ventral mesencephalic grafts. Thus, when trying to rescue dopamine neurons in Parkinson's disease, improving the noradrenergic input to the substantia nigra might be worth considering.


Assuntos
Dopamina/metabolismo , Locus Cerúleo/fisiologia , Mesencéfalo/fisiologia , Neurônios/metabolismo , Família Aldeído Desidrogenase 1 , Animais , Transplante de Tecido Encefálico/métodos , Calbindinas , Comunicação Celular/fisiologia , Sobrevivência Celular/fisiologia , Olho , Feminino , Transplante de Tecido Fetal/métodos , Sobrevivência de Enxerto/fisiologia , Cones de Crescimento/metabolismo , Cones de Crescimento/ultraestrutura , Locus Cerúleo/citologia , Locus Cerúleo/embriologia , Mesencéfalo/citologia , Mesencéfalo/embriologia , Neurônios/citologia , Norepinefrina/metabolismo , Procedimentos Cirúrgicos Oftalmológicos/métodos , Ratos , Ratos Sprague-Dawley , Retinal Desidrogenase/metabolismo , Proteína G de Ligação ao Cálcio S100/metabolismo , Tirosina 3-Mono-Oxigenase/metabolismo
6.
J Comp Neurol ; 515(1): 72-82, 2009 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-19399894

RESUMO

Supplementation of antioxidants to the diet has been proved to be beneficial in aging and after brain injury. Furthermore, it has been postulated that the locus coeruleus promotes survival of dopamine neurons. Thus, this study was performed to elucidate the effects of a blueberry-enriched diet on fetal ventral mesencephalic tissue in the presence or absence of locus coeruleus utilizing the in oculo grafting method. Sprague-Dawley rats were given control diet or diet supplemented with 2% blueberries, and solid tissue pieces of fetal locus coeruleus and ventral mesencephalon were implanted as single and co-grafts. The results revealed that the presence of locus coeruleus tissue or the addition of blueberries enhanced the survival of ventral mesencephalic tyrosine hydroxylase (TH)-positive neurons, whereas no additive effects were observed for the two treatments. The density of TH-positive nerve fibers in ventral mesencephalic tissue was significantly elevated when it was attached to the locus coeruleus or by blueberry treatment, whereas the innervation of dopamine-beta-hydroxylase-positive nerve fibers was not altered. The presence of locus coeruleus tissue or bluberry supplementation reduced the number of Iba-1-positive microglia in the ventral mesencephalic portion of single and co-grafts, respectively, whereas almost no OX6 immunoreactivity was found. Furthermore, neither the attachment of ventral mesencephalic tissue nor the addition of blueberries improved the survival of TH-positive neurons in the locus coerulean grafts. To conclude, locus coeruleus and blueberries are beneficial for the survival of fetal ventral mesencephalic tissue, findings that could be useful when grafting tissue in Parkinson's disease.


Assuntos
Antioxidantes/farmacologia , Transplante de Tecido Encefálico/métodos , Sobrevivência de Enxerto/fisiologia , Mesencéfalo/transplante , Neurônios/metabolismo , Transplante de Células-Tronco/métodos , Animais , Antioxidantes/uso terapêutico , Axônios/efeitos dos fármacos , Axônios/metabolismo , Axônios/ultraestrutura , Mirtilos Azuis (Planta)/química , Comunicação Celular/efeitos dos fármacos , Comunicação Celular/fisiologia , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Dopamina/biossíntese , Feminino , Alimentos Formulados , Sobrevivência de Enxerto/efeitos dos fármacos , Locus Cerúleo/efeitos dos fármacos , Locus Cerúleo/metabolismo , Locus Cerúleo/transplante , Mesencéfalo/efeitos dos fármacos , Mesencéfalo/metabolismo , Neurônios/citologia , Neurônios/efeitos dos fármacos , Procedimentos Cirúrgicos Oftalmológicos/métodos , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Ratos , Ratos Sprague-Dawley , Substância Negra/efeitos dos fármacos , Substância Negra/metabolismo , Substância Negra/transplante , Resultado do Tratamento , Tirosina 3-Mono-Oxigenase/metabolismo
7.
J Neurosci Res ; 86(1): 84-92, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17868150

RESUMO

Grafting fetal ventral mesencephalon has been utilized to alleviate the symptoms of Parkinson's disease. One obstacle in using this approach is the limited outgrowth from the transplanted dopamine neurons. Thus, it is important to evaluate factors that promote outgrowth from fetal dopamine neurons. Proteoglycans (PGs) are extracellular matrix molecules that modulate neuritic growth. This study was performed to evaluate the role of PGs in dopamine nerve fiber formation in organotypic slice cultures of fetal ventral mesencephalon. Cultures were treated with the PG synthesis inhibitor methyl-umbelliferyl-beta-D-xyloside (beta-xyloside) and analyzed using antibodies against tyrosine hydroxylase (TH) to visualize dopamine neurons, S100beta to visualize astrocytes, and neurocan to detect PGs. Two growth patterns of TH-positive outgrowth were observed: nerve fibers formed in the presence of astrocytes and nerve fibers formed in the absence of astrocytes. Treatment with beta-xyloside significantly reduced the distance of glial-associated TH-positive nerve fiber outgrowth but did not affect the length of the non-glial-associated nerve fibers. The addition of beta-xyloside shifted the nerve fiber growth pattern from being mostly glial-guided to being non-glial-associated, whereas the total amount of TH protein was not affected. Further, astrocytic migration and proliferation were impaired after beta-xyloside treatment, and levels of non-intact PG increased. beta-Xyloside treatment changed the distribution of neurocan in astrocytes, from being localized in vesicles to being diffusely immunoreactive in the processes. To conclude, inhibition of PG synthesis affects glial-associated TH-positive nerve fiber formation in ventral mesencephalic cultures, which might be an indirect effect of impaired astrocytic migration.


Assuntos
Astrócitos/fisiologia , Movimento Celular/fisiologia , Mesencéfalo/citologia , Neurônios/fisiologia , Proteoglicanas/metabolismo , Animais , Anticorpos/farmacologia , Astrócitos/efeitos dos fármacos , Contagem de Células/métodos , Movimento Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Embrião de Mamíferos , Inibidores Enzimáticos/farmacologia , Feminino , Glicosídeos/farmacologia , Fatores de Crescimento Neural/metabolismo , Neurônios/efeitos dos fármacos , Técnicas de Cultura de Órgãos , Gravidez , Ratos , Ratos Sprague-Dawley , Subunidade beta da Proteína Ligante de Cálcio S100 , Proteínas S100/metabolismo , Espirostanos , Tirosina 3-Mono-Oxigenase/imunologia , Tirosina 3-Mono-Oxigenase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA